10 Einträge gefunden

1. Identification of HERC5 and its potential role in NSCLC progression

   1. Wrage, Michaela
   2. Hagmann, Wolfgang
   3. Kemming, Dirk
   4. Uzunoglu, Faik G
   5. Riethdorf, Sabine
   6. Harms-Effenberger, Katharina
   7. Westphal, Manfred

   2015 - Forschungsinformationssystem des UKE
2. Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells

   1. Werner, Stefan
   2. Stamm, Hauke
   3. Pandjaitan, Mutiha
   4. Kemming, Dirk
   5. Brors, Benedikt
   6. Pantel, Klaus
   7. Wikman, Harriet

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
3. Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic acid induced 2

   1. Werner, Stefan
   2. Brors, Benedikt
   3. Eick , Julia
   4. Marques, Elsa
   5. Pogenberg, Vivian
   6. Parret, Annabel
   7. Kemming, Dirk

   2015 - Forschungsinformationssystem des UKE
4. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.

   1. Schulte, Alexander
   2. Günther, Hauke
   3. Phillips, Heidi S
   4. Kemming, Dirk
   5. Martens, Tobias
   6. Kharbanda, Samir
   7. Soriano, Robert H

   2011 - Forschungsinformationssystem des UKE
5. Quantitative high-resolution genomic analysis of single cancer cells.

   1. Hannemann, Juliane
   2. Meyer-Staeckling, Sönke
   3. Kemming, Dirk
   4. Alpers, Iris
   5. Joosse, Simon
   6. Pospisil, Heike
   7. Kurtz, Stefan

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
6. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.

   1. Helms, Mike W
   2. Kemming, Dirk
   3. Contag, Christopher H
   4. Pospisil, Heike
   5. Bartkowiak, Kai
   6. Wang, Alice
   7. Chang, Sheng-Yung

   2009 - Forschungsinformationssystem des UKE
7. Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease.

   1. Helms, M W
   2. Kemming, Dirk
   3. Pospisil, H
   4. Vogt, U
   5. Buerger, H
   6. Korsching, E
   7. Liedtke, C

   2008 - Forschungsinformationssystem des UKE
8. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.

   1. Günther, Hauke
   2. Schmidt, Nils-Ole
   3. Phillips, H S
   4. Kemming, Dirk
   5. Kharbanda, S
   6. Soriano, R
   7. Modrusan, Z

   2008 - Forschungsinformationssystem des UKE
9. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.

   1. Martens, Tobias
   2. Laabs, Yvonne
   3. Günther, Hauke
   4. Kemming, Dirk
   5. Zhu, Zhenping
   6. Witte, Larry
   7. Hagel, Christian

   2008 - Forschungsinformationssystem des UKE
10. Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.

    1. Brandt, Burkhard
    2. Mikesch, Jan-Hendrik
    3. Simon, Ronald
    4. Rötger, Antje
    5. Kemming, Dirk
    6. Schier, Katrin
    7. Sauter, Guido

    2005 - Forschungsinformationssystem des UKE